St. Joseph's Hospital / Parkwood Hospital
London, Ontario, N6A 4V2, Canada
NCT Number: NCT01808586
A) Background Chronic neck pain is a significant and common issue which is difficult to treat. Tight bands of muscle (trigger points) can be a source of chronic neck pain and they are sometimes injected to manage chronic neck pain. However, these injections seldom lead to significant, long-lasting relief. In some cases, these trigger points may originate from injury or damage to a specific joint in the neck (the facet joint). Treatment of this joint with cortisone injection may lead to improved pain relief and function.
B) Hypothesis By injecting the facet joint with cortisone, the pain associated with tight bands of muscle in the neck and shoulders will be relieved to a greater extent than that attained through trigger point injection.
C) Methods Patients with neck pain will have a test to determine if any pain originates from the facet joint. Among those who have significant pain from these joints, a comparison between the effect of cortisone injection into these joints versus injection into the trigger points will be evaluated.
D) Expected Results and Significance
It is expected that injection with cortisone into the facet joints will lead to improved pain and function when compared to that attained from trigger point injection. In addition, the number of trigger points, and the pain and headache that originate from these trigger points, are expected to decrease with cortisone injection into the facets to a statistically and clinically significant extent. Results from this pilot study will then influence the design of future trials into chronic neck pain treatment, leading to better clinical recommendations. A peer-reviewed publication and conference presentations will facilitate dissemination.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
London, Ontario, N6A 4V2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 mg/mL injected into the facet joint as dictated by modified dual-comparative medial branch block diagnostic protocol
Other names: Betaject/Celestone
4mg/mL
2%
Standardized home exercise program
Time frame: 1, 3, and 6 months
A 15-point self-report scale ranging from 0 = A very great deal worse to 15 = A very great deal better (8 = no change).
Time frame: 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Constructed specifically for this study.
Time frame: 1, 3, and 6 months
Measured using a digital inclinometer
Time frame: 1, 3, and 6 months
Measured using a digital algometer over standardized myofascial trigger points.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Facet Versus Trigger Point Injection for Management of Chronic Muscular Neck Pain: A Randomized Clinical Trial and Creation of a Clinical Prediction Algorithm
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06835439
Back Pain, Chronic Pain
San Diego, California, United States
View Trial DetailsNCT06849999
Anxiety Disorders, Chronic Pain
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06522893
Chronic Pain, Neck Pain
Almería, Almeria, Spain
View Trial DetailsNCT07462416
Central Nervous System Sensitization, Chronic Pain
Kahramanmaraş, Turkey (Türkiye)
View Trial Details